As of 2025-05-31, the Intrinsic Value of ZIOPHARM Oncology Inc (ZIOP) is -1.91 USD. This ZIOP valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.87 USD, the upside of ZIOPHARM Oncology Inc is -320.34%.
Based on its market price of 0.87 USD and our intrinsic valuation, ZIOPHARM Oncology Inc (ZIOP) is overvalued by 320.34%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -1.91 - -1.91 | -1.91 | -320.34% |
| P/E | (3.76) - (7.94) | (6.14) | -809.6% |
| DDM - Stable | (9.90) - 85.71 | 37.91 | 4278.7% |
| DDM - Multi | (9.19) - 60.95 | (21.43) | -2575.0% |
| Market Cap (mil) | 187.12 |
| Beta | 1.70 |
| Outstanding shares (mil) | 216.15 |
| Enterprise Value (mil) | 119.61 |
| Market risk premium | 4.24% |
| Cost of Equity | 5.25% |
| Cost of Debt | 5.00% |
| WACC | 4.45% |